This white paper introduces a smarter, more sustainable lifecycle management model. Instead of relying solely on promotion, forward-thinking commercial teams are prioritizing prescribing support and reallocating resources to remove friction across the entire product lifecycle.

This paper outlines our vision for empowering patients, demonstrating how a CDMO can play a pivotal role in the advancement of patient-friendly drug delivery systems. We highlight the importance of flexibility and adaptability in manufacturing processes, illustrating how these qualities are essential for bringing innovative solutions to life.

This white paper will explore the value of this “right-now” capability and how developments in causal AI are making it possible in a fast-moving, data-driven universe of tools and technologies. Download now.

This whitepaper examines how adaptive clinical trial designs in oncology can improve patient outcomes and treatment efficacy through real-time modifications, while also highlighting the regulatory and ethical challenges these designs pose within IRB frameworks. 

We interviewed 24 Medical Affairs leaders on the critical success factors for building a Best Practice Medical Affairs organization. This report shares what we learned.